BRIEF published on 11/19/2025 at 00:10, 9 months 22 days ago Le manifeste de l'UEG plaide pour la participation des patients à l'élaboration des politiques de santé digestive Europe Manifeste De L'UEG Santé Digestive Implication Des Patients Réforme Des Politiques
BRIEF published on 11/19/2025 at 00:05, 9 months 22 days ago Onco-Innovations and Kuano Collaborate on PNKP Inhibitor Development AI In Drug Discovery Onco-Innovations PNKP Inhibitor Kuano Quantum Analytics
BRIEF published on 11/19/2025 at 00:05, 9 months 22 days ago Onco-Innovations et Kuano collaborent au développement d'un inhibiteur de PNKP L'IA Dans La Découverte De Médicaments Onco-Innovations Inhibiteur De PNKP Kuano Analyse Quantique
BRIEF published on 11/19/2025 at 00:05, 9 months 22 days ago Grande Portage Engages Machai Capital for Digital Marketing Stock Options Digital Marketing TSXV Grande Portage Machai Capital
BRIEF published on 11/19/2025 at 00:05, 9 months 22 days ago Grande Portage fait appel à Machai Capital pour son marketing numérique TSXV Options D'achat D'actions Grande Portage Marketing Numérique Capitale De Machai
BRIEF published on 11/18/2025 at 23:40, 9 months 22 days ago Biomind Labs Files Disclosure and Appoints New Board Member Cease Trade Order Securities Commission Biomind Labs Disclosure Filing Scott Ackerman
BRIEF published on 11/18/2025 at 23:40, 9 months 22 days ago Biomind Labs publie un rapport et nomme un nouveau membre au conseil d'administration Commission Des Valeurs Mobilières Déclaration De Divulgation Ordonnance De Cessation Des Échanges Scott Ackerman Laboratoires Biomind
BRIEF published on 11/18/2025 at 22:35, 9 months 22 days ago Organto Foods Reports Third Quarter 2025 Financial Growth Sales Increase Debt Restructuring Financial Growth EBITDA Impact Customer Expansion
BRIEF published on 11/18/2025 at 22:35, 9 months 22 days ago Organto Foods annonce une croissance financière au troisième trimestre 2025 Croissance Financière Restructuration De La Dette Expansion De La Clientèle Impact Sur L'EBITDA Les Ventes Augmentent
BRIEF published on 11/18/2025 at 21:27, 9 months 22 days ago Bajaj Gains Sole Control Over PIERER Mobility AG Takeover PIERER Mobility Bajaj Auto Call Option Sole Control
Published on 09/11/2026 at 04:00, 5 hours 17 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 52 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 17 hours 57 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 17 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:05, 12 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 17 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 09:00, 17 minutes ago Mountain Alliance AG invests in Evolved Aerospace and expands its involvement in the European defence technology market
Published on 09/11/2026 at 07:00, 2 hours 17 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 17 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 17 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 47 minutes ago Availability of the 2026 Interim Financial Report
